CR2 and COVID-19: At the same time, recent studies have found that S-specific memory B-cells with the IgD–CD21+CD27+CD38–CD71int/- phenotype are detected in patients who recovered from severe COVID-19 six months ago, suggesting that effective immunity can be induced even in this group of patients [66].